Corpus ID: 86565307

Screening and evaluation of natural compounds for therapeutic application in Alzheimer's disease

@inproceedings{Nirvanashetty2016ScreeningAE,
  title={Screening and evaluation of natural compounds for therapeutic application in Alzheimer's disease},
  author={Somashekara Nirvanashetty},
  year={2016}
}

References

SHOWING 1-10 OF 416 REFERENCES
In vivo inhibition of Aβ production by memapsin 2 (β‐secretase) inhibitors
  • 94
  • Highly Influential
Multi-target-directed ligands in Alzheimer's disease treatment.
  • 172
  • Highly Influential
Accelerated Alzheimer-type phenotype in transgenic mice carrying both mutant amyloid precursor protein and presenilin 1 transgenes
  • 1,304
  • Highly Influential
New pharmacological strategies for treatment of Alzheimer's disease: focus on disease modifying drugs.
  • 268
  • Highly Influential
The projected effect of risk factor reduction on Alzheimer's disease prevalence
  • 1,802
  • Highly Influential
  • PDF
The economic cost of Alzheimer's disease: Family or public health burden?
  • 46
  • Highly Influential
  • PDF
Current Approaches to the Clinical Diagnosis of Alzheimer’s Disease
  • 9
  • Highly Influential
  • PDF
Current drug targets for Alzheimer's disease treatment
  • 181
  • Highly Influential
Alzheimer’s disease: Insights from epidemiology
  • 145
  • Highly Influential
...
1
2
3
4
5
...